Australia markets closed

Nurix Therapeutics, Inc. (NRIX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.87+0.13 (+0.63%)
At close: 04:00PM EDT
20.87 0.00 (0.00%)
After hours: 06:43PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.27B
Enterprise value 1.06B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.08
Price/book (mrq)7.55
Enterprise value/revenue 13.10
Enterprise value/EBITDA -0.77

Trading information

Stock price history

Beta (5Y monthly) 2.17
52-week change 3107.46%
S&P500 52-week change 322.55%
52-week high 322.44
52-week low 34.22
50-day moving average 315.68
200-day moving average 310.91

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 31.89M
Shares outstanding 561.07M
Implied shares outstanding 661.07M
Float 841.77M
% held by insiders 12.18%
% held by institutions 187.20%
Shares short (14 June 2024) 47.6M
Short ratio (14 June 2024) 47.69
Short % of float (14 June 2024) 413.52%
Short % of shares outstanding (14 June 2024) 412.45%
Shares short (prior month 15 May 2024) 47.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Nov 2023
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin -178.93%
Operating margin (ttm)-272.65%

Management effectiveness

Return on assets (ttm)-28.80%
Return on equity (ttm)-65.37%

Income statement

Revenue (ttm)80.89M
Revenue per share (ttm)1.48
Quarterly revenue growth (yoy)30.70%
Gross profit (ttm)N/A
EBITDA -150.9M
Net income avi to common (ttm)-144.73M
Diluted EPS (ttm)-2.66
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)243.99M
Total cash per share (mrq)4.96
Total debt (mrq)29.16M
Total debt/equity (mrq)17.28%
Current ratio (mrq)2.86
Book value per share (mrq)3.43

Cash flow statement

Operating cash flow (ttm)-74.86M
Levered free cash flow (ttm)-34.76M